Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/128218
Campo DC Valoridioma
dc.contributor.authorTorres, Maria Joséen_US
dc.contributor.authorCumplido, Joseen_US
dc.contributor.authorBusset Niraen_US
dc.contributor.authorCaballero Naranjo, Elenaen_US
dc.contributor.authorBlanco, Carlosen_US
dc.contributor.authorHernández, Elisaen_US
dc.contributor.authorCarrillo Díaz, Teresaen_US
dc.date.accessioned2024-01-03T15:46:15Z-
dc.date.available2024-01-03T15:46:15Z-
dc.date.issued2009en_US
dc.identifier.issn1018-9068en_US
dc.identifier.urihttp://hdl.handle.net/10553/128218-
dc.description.abstractBackground: Cysteinyl-leukotrienes are mediators of inflammatory responses in bronchial asthma. We studied the genes encoding the enzymes involved in their synthesis to identify risk factors for asthma. The promoter polymorphisms LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 have been reported to be associated with bronchial asthma. Methods: We analyzed the effects of LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 on asthma susceptibility by means of a case-control study with 193 ethnically matched, unrelated individuals. Participants were classified as severe asthmatics, nonsevere asthmatics, and nonasthmatics, using a combination of 2 techniques: polymerase chain reaction-restricted fragment length polymorphism and multiplex capillary electrophoresis. Results: No association was found between these polymorphisms and asthma, neither individually nor in combination. Conclusion: Although the studied polymorphisms have been previously reported to constitute risk factors for the disease, we found no association between LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 polymorphisms and bronchial asthma.en_US
dc.languageengen_US
dc.relation.ispartofJournal of Investigational Allergology and Clinical Immunologyen_US
dc.sourceJournal of Investigational Allergology and Clinical Immunology [1018-9068], v. 19(3), pp. 453-458en_US
dc.subject32 Ciencias médicasen_US
dc.subject320710 Inmunopatologíaen_US
dc.subject.otherBronchial asthmaen_US
dc.subject.other5-Lipoxygenase pathwayen_US
dc.subject.otherPromoteren_US
dc.subject.otherPolymorphismen_US
dc.subject.otherRisken_US
dc.title5-Lipoxygenase Pathway Gene polymorphisms: Lack of Association with Asthma in Spanish Populationen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.description.lastpage458en_US
dc.identifier.issue6-
dc.description.firstpage453en_US
dc.relation.volume19en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr1,189
dc.description.jcrqQ3
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Patología y Tecnología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-3047-8908-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameCaballero Naranjo, Elena-
crisitem.author.fullNameCarrillo Díaz, Teresa-
Colección:Artículos
Adobe PDF (86,93 kB)
Vista resumida

Visitas

43
actualizado el 30-mar-2024

Descargas

7
actualizado el 30-mar-2024

Google ScholarTM

Verifica


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.